These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16715134)

  • 1. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
    Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
    Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
    Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
    Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
    Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
    Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of RhoC in growth and metastatic capacity of melanoma.
    Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
    J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
    Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
    Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
    Chang YW; Marlin JW; Chance TW; Jakobi R
    Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
    Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
    Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
    Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
    Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
    Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.
    Spangler B; Kappelmann M; Schittek B; Meierjohann S; Vardimon L; Bosserhoff AK; Kuphal S
    Int J Cancer; 2012 Jun; 130(12):2801-11. PubMed ID: 21732343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.
    Mukai M; Endo H; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Inoue M
    Biochem Biophys Res Commun; 2006 Jul; 346(1):74-82. PubMed ID: 16750170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.